Daniel G. Stover MD

Dr. Stover is an Assistant Professor of Medicine at The Ohio State University College of Medicine and the James Cancer Hospital/Solove Research Institute and is a clinician at the Stefanie Spielman Comprehensive Breast Center. His research focuses on clinical computational approaches to understand and treat breast cancer. As a computational biologist and medical oncologist, he applies and develops computational algorithms to integrate genomic data with patient features and outcomes. By studying patient samples, he seeks to identify new mechanisms of drug resistance to standard agents as well as investigational agents such as immunotherapy. The ultimate goal of this work is to identify predictive markers for treatment response while identifying novel susceptibilities to overcome drug resistance. Dr. Stover actively collaborates on correlative studies from early phase clinical trials, including biomarker identification and testing, genomic/transcriptional analyses, and studies using patient-derived tissue. He is an Associated Scientist at the Broad Institute of Harvard and MIT and an active collaborator with the Nurses’ Health Study. Dr. Stover has published papers in Journal of Clinical Oncology, Cell, Nature, Nature Medicine, and Clinical Cancer Research, among others.

Dr. Stover was born and raised in Columbus, Ohio where he lives with his wife and two sons. Both of his parents and all four of his grandparents are alumni of The Ohio State University. Dr. Stover is a cum laude graduate (Molecular Biology) of Princeton University and received his M.D. from Vanderbilt University. Dr. Stover did his residency in internal medicine at Vanderbilt University Medical Center and was selected to serve as the Hugh J. Morgan Chief Resident in Medicine. He completed his fellowship in Medical Oncology at the Dana-Farber Cancer Institute/Massachusetts General Hospital/Harvard Cancer Center program and postdoctoral research in the lab of Joan Brugge, PhD at Harvard Medical School. He then joined the faculty of Harvard Medical School while caring for breast cancer patients at Dana-Farber Cancer Institute and Brigham and Women’s Hospital prior to moving to OSU.